(Press-News.org) OAK BROOK, Ill. – In a new study published in the March issue of Radiology, functional magnetic resonance imaging (fMRI) shows that cognitive rehabilitation changes brain function and improves cognitive performance in patients with relapsing-remitting multiple sclerosis (MS).
"These results prompt the use of specific computer-based rehabilitation programs to treat deficits in selected neuropsychological domains in patients with relapsing-remitting MS," said the study's lead author, Massimo Filippi, M.D., professor of neurology at the San Raffaele Vita-Salute University and director of the "BrainMap" interdepartmental research program and the Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute San Raffaele, Milan, Italy. "They also suggest that fMRI might provide useful metrics to monitor the effects of rehab in MS."
MS is a nervous system disease affecting the brain and spinal cord. MS damages a material called the myelin sheath that surrounds and protects nerve cells. This damage disrupts messages between the brain and other parts of the body, leading to symptoms such as muscle weakness, coordination and balance difficulties, numbness, problems with vision, memory loss and other cognitive issues. MS affects women more than men and often becomes symptomatic between the ages of 20 and 40.
In relapsing-remitting MS, the most common type, patients experience a series of attacks followed by partial or complete disappearance of symptoms. The interval between relapses can range from weeks to years.
Cognitive impairment affects a large proportion of patients with MS in the areas of attention, information processing, executive functions, memory and visual-spatial abilities. Cognitive dysfunction impacts a range of activities, including work, driving and social integration.
For the study, Dr. Filippi and colleagues recruited 20 patients with relapsing-remitting MS. Patients were randomized into two groups of 10. The first group received a 12-week program of computer-assisted cognitive rehabilitation of attention and information processing and executive functions, and the second (control) group received no cognitive rehabilitation.
Aspects of the rehabilitation program included a day-planning task, which employed realistic simulations of a set of scheduled dates and duties to address the patient's ability to organize, plan and develop solution strategies; and an attention task requiring the patient to simulate driving a train, carefully observing the control panel of the train and the countryside while encountering several distractions at increasing levels of difficulty.
All of the patients underwent neuropsychological assessment and MRI exams at baseline and after 12 weeks. As compared to their performance at baseline, the patients in the treatment group improved in tests of attention and information processing and executive functions. The fMRI results showed modifications in activity in several brain regions in the rehabilitation group, compared to the non-rehabilitation group. These fMRI modifications were correlated with cognitive improvement.
Analysis after cognitive rehabilitation found no structural changes in the gray matter or normal-appearing white matter of the brain in the treatment group.
"The findings demonstrated that computer-assisted cognitive rehabilitation in patients with MS results in an improvement of the trained cognitive functions," Dr. Filippi said. "However, the structural integrity of the brain's gray matter and white matter showed no modifications in these patients, suggesting an impairment of structural plasticity."
###
"Multiple Sclerosis: Effects of Cognitive Rehabilitation on Structural and Functional MR Imaging Measures—An Explorative Study." Collaborating with Dr. Filippi were Gianna Riccitelli, Ph.D., Flavia Mattioli, M.D., Ruggero Capra, M.D., Chiara Stampatori, Ph.D., Elisabetta Pagani, M.Sc., Paola Valsasina, M.Sc., Massimiliano Copetti, Ph.D., Andrea Falini, M.D., Giancarlo Comi, M.D., and Maria Assunta Rocca, M.D.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (http://radiology.rsna.org/)
RSNA is an association of more than 48,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on fMRI, visit RadiologyInfo.org.
END
If people see news coverage of alcohol's role in violent crime and fatal injuries, they may give more support to alcohol-control laws, according to a study in the March issue of the Journal of Studies on Alcohol and Drugs.
It's estimated that drinking is involved in almost one third of deaths from accidents and violent crime. But the news reports on those deaths often make no mention of alcohol.
"People have some awareness of the social cost that alcohol can have," said the study's lead author, Michael D. Slater, Ph.D., of Ohio State University in Columbus. "But only ...
A pioneering new study finds that a specific type of computerized cognitive training can lead to significant neural and behavioral improvements in individuals with schizophrenia. The research, published by Cell Press in the February 23 issue of the journal Neuron, reveals that 16 weeks of intensive cognitive training is also associated with improved social functioning several months later and may have far-reaching implications for improving the quality of life for patients suffering from neuropsychiatric illness.
Schizophrenia is a debilitating psychiatric illness that ...
What: NIH-supported scientists will be presenting their latest research findings at the 2012 Midwinter Meeting of the Association for Research in Otolaryngology (ARO).
When: February 25-29, 2012
Where: The Manchester Grand Hyatt Hotel, San Diego, California, USA
Additional Information: Research topics to be presented by NIDCD-funded scientists will include:
Bilateral ≠ Binaural: Can the Ability to Localize Sounds Be Regained After Bilateral Cochlear Implantation?
Ruth Litovsky, Ph.D., University of Wisconsin-Madison
Bilateral cochlear implants—one implant ...
PHILADELPHIA - The infamous BRCA genes do not act alone in causing cancer; there is a molecular syndicate at work preventing the way cells normally repair breaks in DNA that is at the root of breast cancer. But finding all of the BRCA molecular collaborators has been elusive.
Researchers at the Perelman School of Medicine at the University of Pennsylvania and the University of Oulu, Finland, published their discovery of a mutation in the Abraxas gene, which interacts with the well-known breast-cancer gene BRCA1, in Science Translational Medicine this week.
The mutation ...
STANFORD, Calif. — When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate an aortic defense.
A team led by cardiovascular scientists Philip Tsao, PhD, and Joshua Spin, MD, PhD, identified two microRNAs — small molecules that usually block proteins from being made — that work to strengthen the aorta during bulge growth. By tweaking the activity of each molecule, they could reduce abdominal aortic ...
Recently, the National Transportation Safety Board (NTSB) called for every state in the nation and Washington, D.C., to ban all non-emergency cellphone use while driving a motor vehicle. This recommendation follows various studies that have concluded cellphone use while driving can be extremely distracting - often leading to severe or even deadly accidents.
One tragic trucking accident illustrating the NTSB's concerns was an accident in which a truck driver, while using his cellphone, crossed the median and hit a van, killing 11 people in the process. It remains to be ...
Two independent groups of researchers — one led by Adrian Clark, at Queen Mary University of London, United Kingdom; and the other led by Jean-Laurent Casanova, at The Rockefeller University, New York — have now identified the disease-causing gene in patients with a complex inherited syndrome most commonly observed in the Irish Traveller community. As noted by Jordan Orange, at the University of Pennsylvania School of Medicine, Philadelphia, in an accompanying commentary, the new data provide deep mechanistic insight into a complex human condition and expand our understanding ...
Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a team of researchers led by John Crispino, at Northwestern University, Chicago, has now identified a potential explanation as to why children with DS are at increased risk of AMKL. In doing so, they have also identified a candidate therapeutic target.
DS is a genetic condition in which a person has an extra copy of chromosome 21 (they have 3 copies rather ...
EDITOR'S PICK: Unraveling why children with Down syndrome have increased leukemia risk
Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a team of researchers led by John Crispino, at Northwestern University, Chicago, has now identified a potential explanation as to why children with DS are at increased risk of AMKL. In doing so, they have also identified a candidate therapeutic target.
DS is a genetic ...
Researchers from UCLA's Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the United States and Australia, report for the first time that a newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is treated.
The data comes from an international Phase II study of Zelboraf that included 132 patients followed for at least one year.
Patients with this advanced form of melanoma that has spread to other organs typically survive about ...
